The ENGAGE Trial (Status: Completed)
Through the ENGAGE trial, our research team collaborated with consumers and representatives from the Leukaemia Foundation to design a 12-week nurse-led survivorship intervention (ENGAGE Intervention) that aimed to improve health-related quality of life in patients who had recently completed curative intent treatment for lymphoma. This intervention included a tailored survivorship care plan, evidence-based education incorporating self-management strategies, and referrals to specialised services. Telehealth technologies were used to ensure people in regional, rural and remote areas could receive the intervention. This pilot RCT will inform a pragmatic, phase III RCT which will ultimately evaluate the effectiveness and cost-effectiveness of a structured post-treatment survivorship intervention for patients with lymphoma.
The ENGAGE Trial is now completed. We are currently preparing a publication for submission to a peer reviewed journal. We will share a link to the article once the article is published.
For more information, please contact Professor Raymond Chan.